LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/FTC Sends “Second Request” to Zimmer/Biomet
Legal & Regulatory and Reimbursement

FTC Sends “Second Request” to Zimmer/Biomet

July 3, 2014 2 min read Premium comments

Advertisement

FTC Sends “Second Request” to Zimmer/Biomet
Mergers Review /F Source: ederal Trade Commission
Secondary

The Federal Trade Commission (FTC) has sent Zimmer Holdings, Inc. and Biomet, Inc. a “Second Request” for additional information in connection with their proposed merger.

According to former FTC attorney Darren Tucker, only about 4% of all deals receive a formal second request for information. Tucker worked on the Johnson & Johnson/Synthes merger while at the agency. This second request follows European regulators pausing their review of the deal until further information is provided by the companies.

Tucker, now at Bingham McCutchen, told OTW on July 2, 2014, that the issuance of a second request is not surprising, given the sizable overlaps between the two companies. “The parties still have good prospects for FTC approval of their transaction without conditions, on account of the three strong rivals that will remain in the hip and knee segments and the sophistication of the customers.”

Second Request

He said the second request gives the FTC an opportunity to obtain additional information from the parties, their customers, and other market participants.

“At the Second Request stage, the FTC can compel documents and information from third parties, rather than rely on voluntary submissions. Some of the things the FTC will be looking at include the extent to which the parties’ ordinary-course documents discuss competition between the firms, the frequency and intensity of competition between the two firms for sales, the similarity of the two firms’ products, the ability of rivals to reposition their product offerings in response to the merger, and potential efficiencies from the transaction, ” added Tucker.

Compliance with a second request, according to Tucker, typically takes about five months, followed by an additional one-month waiting period for the FTC to make an enforcement decision.

“Quick Look”

Advertisement

However, when the FTC’s concerns are less serious or are focused on a particular area, Tucker said it may do a so-called “quick look” investigation, which focuses on one or two dispositive issues while deferring compliance with the full second request. “It would not be surprising for the FTC to do a ‘quick look’ investigation here, focusing on the ability of customers to obtain competitive products from other suppliers in the event that the merged firm tried to raise prices post-transaction.”

Bank of America analyst Bob Hopkins estimates that a Zimmer/Biomet combined shoulder market share would be roughly 50% and in partial knees, the merged companies would be the #1 player. In Hopkins’ view, if Zimmer/Biomet need to divest one of their shoulder or partial knee businesses, “there would be ready buyers for either.”

A statement from Zimmer said the companies still expect to close the transaction in the first quarter of 2015.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy